Future and scope of sirolimus-coated balloon in peripheral vascular treatment

Learning Objectives

To learn about the emerging sirolimus-coated balloon (SCB) technology in peripheral vascular treatment
To learn about SCB with NANOLUTE technology and its clinical outcome in below-the-knee (BTK) and superficial femoral artery (SFA) indications
To learn about SCB with NANOLUTE technology and its clinical outcome in arteriovenous fistula (AVF) and arteriovenous graft (AVG) indications

Presentations available when logged in:

Session objectives
The Magic Touch – PTA – Sirolimus-coated balloon – Insights from preclinical evaluation
Science behind Nanolute technology of sirolimus-coated balloon
Xtosi study: first in man study of clinical use and safety of sirolimus-coated PTA balloon in the treatment of infrainguinal arterial disease
Sirolimus coated PTA balloon initial experience and case reports
Case 1
Case 2
Sirolimus-coated balloon for salvage thrombus arteriovenous graft – Interim results and future RCT design
Thrombolysis of arteriovenous graft and treatment with sirolimus-coated balloon - Case discussion

Your free My PCR account will enable you to: